Rate My Professor Nick Wareham

Professor Nick Wareham is Professor of Epidemiology in the School of Clinical Medicine at the University of Cambridge. He has served as Director of the MRC Epidemiology Unit since 2003 and Co-Director of the Institute of Metabolic Science. He qualified in medicine with an MB BS from St Thomas’ Hospital Medical School, London, and trained in epidemiology and public health at the London School of Hygiene and Tropical Medicine, Harvard University, and the University of Cambridge, earning MSc and PhD degrees. He holds qualifications including FRCP, FFPHM, and is a Fellow of the Academy of Medical Sciences (FMedSci). Previously a Wellcome Trust Senior Fellow in Clinical Science, he is also an Honorary Consultant Physician at Addenbrooke’s Hospital.

Wareham’s research specializations centre on the aetiology and prevention of obesity, type 2 diabetes, and related metabolic disorders. His academic interests include gene-environment interactions, the genetic basis of obesity and diabetes through the Genetics of Energy Metabolism consortium, and the development of novel methods for measuring energy expenditure and physical activity in population studies. He leads the Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life programme as Director, Programme Leader, and MRC Investigator. Key appointments include Principal Investigator of the EPIC-Norfolk study, leader of the diabetes, obesity, and physical activity working group in EPIC-Europe, coordinator of the InterAct EU-funded project on gene-lifestyle interactions in type 2 diabetes, and co-lead of the ADDITION trial on diabetes screening and cardiovascular risk reduction. He directs the Centre for Diet and Activity Research (CEDAR), the NIHR Global Health Group on Diet and Activity, and Population Health Improvement UK. Awards include the Kroc Lecturer and Award from the University of Uppsala (2007) and the Joseph J Hoet Memorial Lecturer and Menarini Award (2008). He has chaired the NICE Programme Development Group on prediabetes prevention, served on WHO Expert Groups, MRC boards, and the editorial board of Diabetologia, contributing significantly to public health policy and metabolic epidemiology.